| International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma S Kumar, B Paiva, KC Anderson, B Durie, O Landgren, P Moreau, ... The lancet oncology 17 (8), e328-e346, 2016 | 2918 | 2016 |
| Lenalidomide after stem-cell transplantation for multiple myeloma PL McCarthy, K Owzar, CC Hofmeister, DD Hurd, H Hassoun, ... New England Journal of Medicine 366 (19), 1770-1781, 2012 | 1387 | 2012 |
| Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients HM Lazarus, ON Koc, SM Devine, P Curtin, RT Maziarz, HK Holland, ... Biology of blood and marrow transplantation 11 (5), 389-398, 2005 | 1210 | 2005 |
| A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved … CS Cutler, SJ Lee, P Greenberg, HJ Deeg, WS Pérez, C Anasetti, ... Blood 104 (2), 579-585, 2004 | 871 | 2004 |
| Risk factors for acute GVHD and survival after hematopoietic cell transplantation M Jagasia, M Arora, MED Flowers, NJ Chao, PL McCarthy, CS Cutler, ... Blood, The Journal of the American Society of Hematology 119 (1), 296-307, 2012 | 855 | 2012 |
| Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report A Palumbo, S Bringhen, MV Mateos, A Larocca, T Facon, SK Kumar, ... Blood, The Journal of the American Society of Hematology 125 (13), 2068-2074, 2015 | 849 | 2015 |
| Lenalidomide maintenance after autologous stem-cell transplantation in newly diagnosed multiple myeloma: a meta-analysis PL McCarthy, SA Holstein, MT Petrucci, PG Richardson, C Hulin, P Tosi, ... Journal of Clinical Oncology 35 (29), 3279-3289, 2017 | 745 | 2017 |
| Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse SJ Lee, JP Klein, AJ Barrett, O Ringden, JH Antin, JY Cahn, MH Carabasi, ... Blood, The Journal of the American Society of Hematology 100 (2), 406-414, 2002 | 677 | 2002 |
| International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment MA Dimopoulos, P Sonneveld, N Leung, G Merlini, H Ludwig, E Kastritis, ... Journal of Clinical Oncology 34 (13), 1544-1557, 2016 | 478 | 2016 |
| Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research S Arai, M Arora, T Wang, SR Spellman, W He, DR Couriel, ... Biology of blood and marrow transplantation 21 (2), 266-274, 2015 | 468 | 2015 |
| High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. KH Antman, PA Rowlings, WP Vaughan, CJ Pelz, JW Fay, KK Fields, ... Journal of Clinical Oncology 15 (5), 1870-1879, 1997 | 391 | 1997 |
| Triplet therapy, transplantation, and maintenance until progression in myeloma PG Richardson, SJ Jacobus, EA Weller, H Hassoun, S Lonial, NS Raje, ... New England Journal of Medicine 387 (2), 132-147, 2022 | 355 | 2022 |
| Outcome of transplantation for myelofibrosis KK Ballen, S Shrestha, KA Sobocinski, MJ Zhang, A Bashey, BJ Bolwell, ... Biology of Blood and Marrow Transplantation 16 (3), 358-367, 2010 | 354 | 2010 |
| Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data A Palumbo, S Bringhen, SK Kumar, G Lupparelli, S Usmani, A Waage, ... The lancet oncology 15 (3), 333-342, 2014 | 346 | 2014 |
| Allogeneic bone marrow transplantation for low-grade lymphoma K Van Besien, KA Sobocinski, PA Rowlings, SC Murphy, JO Armitage, ... Blood, The Journal of the American Society of Hematology 92 (5), 1832-1836, 1998 | 336 | 1998 |
| Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group J Laubach, L Garderet, A Mahindra, G Gahrton, J Caers, O Sezer, ... Leukemia 30 (5), 1005-1017, 2016 | 315 | 2016 |
| Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS SM Luger, O Ringdén, MJ Zhang, WS Pérez, MR Bishop, M Bornhauser, ... Bone marrow transplantation 47 (2), 203-211, 2012 | 312 | 2012 |
| New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG) EM Ocio, PG Richardson, SV Rajkumar, A Palumbo, MV Mateos, ... Leukemia 28 (3), 525-542, 2014 | 310 | 2014 |
| Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of … T Hahn, PL McCarthy Jr, A Hassebroek, C Bredeson, JL Gajewski, ... Journal of Clinical Oncology 31 (19), 2437-2449, 2013 | 280 | 2013 |
| IMWG consensus on maintenance therapy in multiple myeloma H Ludwig, BGM Durie, P McCarthy, A Palumbo, J San Miguel, B Barlogie, ... Blood, The Journal of the American Society of Hematology 119 (13), 3003-3015, 2012 | 277 | 2012 |
